ID: ALA3215358

Max Phase: Preclinical

Molecular Formula: C63H96NNaO12S

Molecular Weight: 1092.53

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCCCCCCCCCCCC/C=C/[C@@H](OCc1ccccc1)[C@H](CO[C@@H]1O[C@@H](COCc2ccccc2)[C@@H](OC(C)=O)[C@H](OS(=O)(=O)[O-])[C@@H]1OCc1ccccc1)NC(=O)CCCCCCCCCCCCCCC.[Na+]

Standard InChI:  InChI=1S/C63H97NO12S.Na/c1-4-6-8-10-12-14-16-18-20-22-24-26-37-45-57(71-48-54-41-33-29-34-42-54)56(64-59(66)46-38-27-25-23-21-19-17-15-13-11-9-7-5-2)50-73-63-62(72-49-55-43-35-30-36-44-55)61(76-77(67,68)69)60(74-52(3)65)58(75-63)51-70-47-53-39-31-28-32-40-53;/h28-37,39-45,56-58,60-63H,4-27,38,46-51H2,1-3H3,(H,64,66)(H,67,68,69);/q;+1/p-1/b45-37+;/t56-,57+,58-,60+,61-,62-,63+;/m0./s1

Standard InChI Key:  BBWCECGHPANWFY-YFLYATGTSA-M

Associated Targets(Human)

P-selectin 551 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 1092.53Molecular Weight (Monoisotopic): 1091.6731AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Marinier A, Martel A, Banville J, Bachand C, Remillard R, Lapointe P, Turmel B, Menard M, Harte WE, Wright JJ, Todderud G, Tramposch KM, Bajorath J, Hollenbaugh D, Aruffo A..  (1997)  Sulfated galactocerebrosides as potential antiinflammatory agents.,  40  (20): [PMID:9379443] [10.1021/jm9606960]

Source